CLINICAL_TRIALS
trial_result
· 2022-10-14
Clinical Trial Update: Pitolisant in Refractory Restless Legs Syndrome [Phase 4]
Summary
Phase 4 clinical trial update for pitolisant in refractory restless legs syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: William Ondo, MD | Conditions: Restless Legs Syndrome | Phase 4 | Status: UNKNOWN